Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Pediatr Blood Cancer ; 64(8)2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28205381

RESUMO

BACKGROUND: Medulloblastoma (MB) is the most common malignant brain tumor of childhood, with cerebrospinal fluid spread the most common site of metastasis. Currently, children diagnosed with MB and evidence of spinal metastasis are treated with an increased dose of craniospinal radiation (CSI). This report reviewed equivocal abnormalities including nerve root clumping, linear vascular enhancement, nerve root enhancement and/or other vague findings on spinal magnetic resonance imaging (MRI) to elucidate their prognostic significance and aid in risk stratification. METHODS: This retrospective cohort study identified children (≥3 years) diagnosed with MB between 1988 and 2012. Children treated with upfront CSI were included, and staging spine MRI must have been done preoperatively or within 72 hr of primary tumor resection. Initial MRI of the spine was assessed by two independent reviewers blinded to outcome to evaluate for equivocal findings. Survival analysis was done to determine impact on prognosis. RESULTS: One hundred of 157 patients were eligible for the analysis. Equivocal findings were identified in 48 (48%) patients, with MRI done preoperatively in 45 (94%) patients. Analysis by subgroup identified a higher proportion of equivocal findings in the sonic hedgehog (SHH) subgroup (P = 0.007). Five-year overall survival (OS) in children with equivocal findings compared to those with normal MRI was not different, 80 vs. 84.8% respectively, while OS in M3 patients was worse at 54.7% (P = 0.02). CONCLUSION: A higher proportion of equivocal findings was identified in the SHH subgroup. This institutional retrospective review demonstrates equivocal findings are common, not associated with decreased OS and should not prompt increased dose of CSI.


Assuntos
Neoplasias Cerebelares/diagnóstico por imagem , Meduloblastoma/diagnóstico por imagem , Medula Espinal/diagnóstico por imagem , Adolescente , Neoplasias Cerebelares/mortalidade , Criança , Pré-Escolar , Estudos de Coortes , Intervalo Livre de Doença , Feminino , Humanos , Estimativa de Kaplan-Meier , Imageamento por Ressonância Magnética , Masculino , Meduloblastoma/mortalidade , Prognóstico , Estudos Retrospectivos , Neoplasias da Medula Espinal/diagnóstico por imagem , Neoplasias da Medula Espinal/secundário
2.
Neuropediatrics ; 47(5): 293-307, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27337547

RESUMO

Our understanding of cerebellar tonsillar herniation evolved over time and nowadays various pathomechanisms have been proposed. Causes of tonsillar herniation share a discrepancy between content (fore- and hindbrain) and container (supratentorial cranial vault, posterior fossa), may be associated with abnormalities of the craniocervical junction, and may have a developmental or acquired nature. In tonsillar herniation, the hindbrain is not malformed but deformed. Accordingly, "Chiari type 1 deformity," not "Chiari type 1 malformation" is the correct term to characterize primary tonsillar herniation. Chiari type 1 deformity is commonly seen in pediatric neurology, neuroradiology, and neurosurgery and may have various clinical presentations depending on patient age. In addition, Chiari type 1 deformity is increasingly found by neuroimaging studies as an incidental finding in asymptomatic children. An accurate and reliable selection of patients based on clinical and neuroimaging findings is paramount for the success of neurosurgical treatment. Future studies are needed to provide selection criteria with a higher sensitivity and specificity.


Assuntos
Malformação de Arnold-Chiari/diagnóstico por imagem , Vértebras Cervicais/diagnóstico por imagem , Fossa Craniana Posterior/diagnóstico por imagem , Encefalocele/diagnóstico por imagem , Siringomielia/diagnóstico por imagem , Malformação de Arnold-Chiari/complicações , Malformação de Arnold-Chiari/fisiopatologia , Malformação de Arnold-Chiari/terapia , Ataxia/etiologia , Vértebras Cervicais/anormalidades , Tratamento Conservador , Fossa Craniana Posterior/anormalidades , Gerenciamento Clínico , Encefalocele/fisiopatologia , Encefalocele/cirurgia , Cefaleia/etiologia , Humanos , Imageamento por Ressonância Magnética , Cervicalgia/etiologia , Neuroimagem , Procedimentos Neurocirúrgicos , Nistagmo Patológico/etiologia , Base do Crânio/anormalidades , Base do Crânio/diagnóstico por imagem , Siringomielia/fisiopatologia , Siringomielia/terapia
3.
Egypt J Immunol ; 16(1): 27-38, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20726320

RESUMO

B cells from systemic lupus erythematosus (SLE) patients display signalling defects that may underlie disease pathogenesis activity.CD19 and CD22 play a major role as regulators of B-cell response. The aim of this study was to clarify the relationship between B cell surface markers namely CD19, CD20 and CD22 expression and clinical and laboratory indices of SLE activity. The study included 33 SLE patients and 20 healthy children and adolescents as controls. Flowcytometric assay of dual markers, CD19/CD20, and CD20/CD22 was done. SLE disease activity was assessed by SLEDAI score. CD22% was significantly higher while CD20% was significantly lower in the study compared to the control group. No significant difference was observed in both groups with respect to CD19% or CD19/CD22% ratio. The level of CD22 expression was significantly lower in high and very high active cases than in mild and moderate cases and negatively correlated with SLDEAI score and ESR. Results obtained showed that, B cell surface receptors CD20 and CD22 are significantly affected in patients with SLE, pointing to their possible involvement in the aetiopathogenesis of the disease and in the regulatory mechanisms in response to the immune disturbance.


Assuntos
Antígenos CD19/imunologia , Linfócitos B/imunologia , Regulação da Expressão Gênica/imunologia , Lúpus Eritematoso Sistêmico/imunologia , Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico/imunologia , Adolescente , Antígenos CD19/sangue , Antígenos CD20/sangue , Antígenos CD20/imunologia , Linfócitos B/metabolismo , Linfócitos B/patologia , Criança , Pré-Escolar , Egito , Feminino , Humanos , Lactente , Lúpus Eritematoso Sistêmico/sangue , Lúpus Eritematoso Sistêmico/patologia , Masculino , Lectina 2 Semelhante a Ig de Ligação ao Ácido Siálico/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA